Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4'-di-n-octyl genistein.

Ning Y, Luo C, Ren K, Quan M, Cao J.

Mol Med Rep. 2014 May;9(5):1982-8. doi: 10.3892/mmr.2014.2012. Epub 2014 Mar 6.

PMID:
24604613
2.
3.

Apoptosis induced by 7-difluoromethoxyl-5,4'-di-n-octyl genistein via the inactivation of FoxM1 in ovarian cancer cells.

Ning Y, Li Q, Xiang H, Liu F, Cao J.

Oncol Rep. 2012 Jun;27(6):1857-64. doi: 10.3892/or.2012.1739. Epub 2012 Mar 22.

PMID:
22447287
4.

7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells.

Cao X, Ren K, Song Z, Li D, Quan M, Zheng Y, Cao J, Zeng W, Zou H.

Oncol Rep. 2016 Aug;36(2):1157-65. doi: 10.3892/or.2016.4848. Epub 2016 Jun 2.

PMID:
27279287
5.

7-difluoromethoxyl-5,4'-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1.

Xiang HL, Liu F, Quan MF, Cao JG, Lv Y.

World J Gastroenterol. 2012 Sep 7;18(33):4618-26. doi: 10.3748/wjg.v18.i33.4618.

6.

Apigenin inhibits the self-renewal capacity of human ovarian cancer SKOV3‑derived sphere-forming cells.

Tang AQ, Cao XC, Tian L, He L, Liu F.

Mol Med Rep. 2015 Mar;11(3):2221-6. doi: 10.3892/mmr.2014.2974. Epub 2014 Nov 18.

PMID:
25405327
7.

Requirement of JNK signaling for self-renewal and tumor-initiating capacity of ovarian cancer stem cells.

Seino M, Okada M, Shibuya K, Seino S, Suzuki S, Ohta T, Kurachi H, Kitanaka C.

Anticancer Res. 2014 Sep;34(9):4723-31.

PMID:
25202050
8.

Inactivation of AKT, ERK and NF-κB by genistein derivative, 7-difluoromethoxyl-5,4'-di-n-octylygenistein, reduces ovarian carcinoma oncogenicity.

Ning Y, Xu M, Cao X, Chen X, Luo X.

Oncol Rep. 2017 Aug;38(2):949-958. doi: 10.3892/or.2017.5709. Epub 2017 Jun 9.

PMID:
28627607
9.

Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism.

Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z, Wang X, Huss WJ, Lele SB, Morrison CD, Odunsi K.

PLoS One. 2014 Jan 7;9(1):e84941. doi: 10.1371/journal.pone.0084941. eCollection 2014.

10.

Apigenin inhibits HeLa sphere-forming cells through inactivation of casein kinase 2α.

Liu J, Cao XC, Xiao Q, Quan MF.

Mol Med Rep. 2015 Jan;11(1):665-9. doi: 10.3892/mmr.2014.2720. Epub 2014 Oct 21.

PMID:
25334018
11.

The expression and significance of pThr32-FOXO3a in human ovarian cancer.

Lu M, Xiang J, Xu F, Wang Y, Yin Y, Chen D.

Med Oncol. 2012 Jun;29(2):1258-64. doi: 10.1007/s12032-011-9919-7. Epub 2011 Mar 31.

PMID:
21452041
12.

Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.

Zhang J, Wang W, Qian L, Zhang Q, Lai D, Qi C.

Oncol Rep. 2015 Nov;34(5):2375-84. doi: 10.3892/or.2015.4213. Epub 2015 Aug 20.

PMID:
26323892
13.

Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.

Ma L, Lai D, Liu T, Cheng W, Guo L.

Acta Biochim Biophys Sin (Shanghai). 2010 Sep;42(9):593-602. doi: 10.1093/abbs/gmq067. Epub 2010 Aug 12.

PMID:
20705681
14.

KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.

Dong Z, Yang L, Lai D.

Cell Prolif. 2013 Aug;46(4):425-35. doi: 10.1111/cpr.12043.

PMID:
23869764
15.

Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.

Yasuda K, Torigoe T, Morita R, Kuroda T, Takahashi A, Matsuzaki J, Kochin V, Asanuma H, Hasegawa T, Saito T, Hirohashi Y, Sato N.

PLoS One. 2013 Aug 13;8(8):e68187. doi: 10.1371/journal.pone.0068187. eCollection 2013.

16.

[Effects of chrysin on sphere formation and CK2α expression of ovarian cancer stem-like cells derived from SKOV3 cell line].

Li HZ, Chen YH, Fang YL, Zhong LY, Yuan QQ, Xu XY, Cao JG.

Zhonghua Yi Xue Za Zhi. 2016 Jul 5;96(25):2013-6. doi: 10.3760/cma.j.issn.0376-2491.2016.25.012. Chinese.

PMID:
27470961
17.

Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens.

Yao X, Dong Z, Zhang Q, Wang Q, Lai D.

BMC Cancer. 2015 Dec 16;15:956. doi: 10.1186/s12885-015-1973-7.

18.

Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.

Xiang T, Long H, He L, Han X, Lin K, Liang Z, Zhuo W, Xie R, Zhu B.

Oncogene. 2015 Jan 8;34(2):165-76. doi: 10.1038/onc.2013.537. Epub 2013 Dec 23.

PMID:
24362529
19.

The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation.

Xu X, Dong Z, Li Y, Yang Y, Yuan Z, Qu X, Kong B.

Int J Biochem Cell Biol. 2013 Mar;45(3):536-45. doi: 10.1016/j.biocel.2012.12.010. Epub 2012 Dec 20.

PMID:
23262295
20.

The identification of the biological characteristics of human ovarian cancer stem cells.

Yan HC, Fang LS, Xu J, Qiu YY, Lin XM, Huang HX, Han QY.

Eur Rev Med Pharmacol Sci. 2014 Nov;18(22):3497-503.

Supplemental Content

Support Center